| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/02/1999 | US5866328 Fast DNA sequence determination method by measuring energy of base pairing or unpairing of nucleic acid sequences and use thereof in sequencing and diagnostics |
| 02/02/1999 | US5866327 Association of kinensin with sensitivity to chemotherapeutic drugs |
| 02/02/1999 | US5866326 Hybrids |
| 02/02/1999 | US5866325 Hybrids; detection, quantitative analysis |
| 02/02/1999 | US5866324 Method of detecting expression of proteins closely related to opioid receptors |
| 02/02/1999 | US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors |
| 02/02/1999 | US5866320 Detection antibodies |
| 02/02/1999 | US5866136 Recombinant vaccine |
| 02/02/1999 | US5866134 Administering polysaccharide antibody and interleukins |
| 02/02/1999 | US5866131 Recombinant vaccine |
| 02/02/1999 | US5866130 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 02/02/1999 | US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA |
| 02/02/1999 | US5866126 Complexing |
| 02/02/1999 | US5866125 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 02/02/1999 | US5866124 Antiidiotypic antibodies for high molecular weight-melanoma associated antigen |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | US5866121 Method for targeting degradation of intracellular proteins |
| 02/02/1999 | US5866119 Hybridization; complexing |
| 02/02/1999 | US5866118 Reducing phytate levels ing composite feeds |
| 02/02/1999 | US5866114 Macrophage colony stimulating factor |
| 02/02/1999 | US5865796 Gas driven gene delivery instrument |
| 02/02/1999 | CA2100671C Serine rich peptide linkers |
| 02/02/1999 | CA2084346C Peptide with inhibitory activity towards plant pathogenic fungi |
| 02/02/1999 | CA2082906C Electrophoretic resolution of single strand dna by asymmetric field inversion |
| 02/02/1999 | CA1340379C Antimicrobial peptide, compositions containing same and uses thereof |
| 02/02/1999 | CA1340378C Non-nuclear chromosomal transformation |
| 02/02/1999 | CA1340374C Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
| 02/02/1999 | CA1340373C Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin |
| 02/02/1999 | CA1340372C Production of e. coli lt-b enterotoxin subunit |
| 02/02/1999 | CA1340371C Methods and products for facile microbial expression of dna sequences |
| 02/02/1999 | CA1340368C Detection, quantitation and classification of ras proteins in body fluids and tissues |
| 02/02/1999 | CA1340366C Proteolytic enzymes and their use in detergents' |
| 02/02/1999 | CA1340363C Mutant acidic fibroblast growth factor |
| 02/01/1999 | CA2244403A1 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array |
| 02/01/1999 | CA2238672A1 Seca |
| 02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
| 01/31/1999 | CA2244314A1 Process for producing nucleoside derivatives |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999004267A2 Test device and method for detecting an analyte in a sample |
| 01/28/1999 | WO1999004266A2 Interactions of atm, atr or dna-pk with p53 |
| 01/28/1999 | WO1999004265A2 Cancer associated nucleic acids and polypeptides |
| 01/28/1999 | WO1999004237A2 Diagnosis of spongiform encephalopathies using prionins |
| 01/28/1999 | WO1999004041A1 Methods and compositions for modulating melting temperatures of nucleic acids |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999004035A1 In vitro method for providing templates for dna sequencing |
| 01/28/1999 | WO1999004026A2 Lentiviral vectors |
| 01/28/1999 | WO1999004025A1 Improvements in or relating to expression of nucleic acid sequences in cerebellar cells |
| 01/28/1999 | WO1999004024A2 Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds |
| 01/28/1999 | WO1999004023A1 Induction of male sterility in plants by expression of high levels of avidin |
| 01/28/1999 | WO1999004022A1 Special virus dna fragments and their use as promoter |
| 01/28/1999 | WO1999004021A1 Dna sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants |
| 01/28/1999 | WO1999004020A1 Use of a virus dna as promoter |
| 01/28/1999 | WO1999004019A1 Increasing production of proteins in gram-positive microorganisms |
| 01/28/1999 | WO1999004018A1 Chimeric contraceptive vaccines |
| 01/28/1999 | WO1999004017A1 Recombinant staphylokinase and their high expression engineered strain |
| 01/28/1999 | WO1999004016A2 Proteases from gram-positive organisms |
| 01/28/1999 | WO1999004015A1 Microorganism and esterase obtained therefrom |
| 01/28/1999 | WO1999004014A2 Transformed yeast strains and their use for the production of monoterminal and diterminal aliphatic carboxylates |
| 01/28/1999 | WO1999004013A2 The induction of stress-related factors in plants |
| 01/28/1999 | WO1999004012A1 Production of pathogen resistant plants |
| 01/28/1999 | WO1999004011A2 Hiv-1 group o antigens and uses thereof |
| 01/28/1999 | WO1999004010A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
| 01/28/1999 | WO1999004009A1 Method of dna vaccination using dna encoding antigen and encoding il6 |
| 01/28/1999 | WO1999004008A2 Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 01/28/1999 | WO1999004007A1 Increasing production of proteins in gram-positive microorganisms |
| 01/28/1999 | WO1999004006A1 Increasing production of proteins in gram-positive microorganisms |
| 01/28/1999 | WO1999004005A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 01/28/1999 | WO1999004004A1 A plant homolog of yeast ada2, a transcription adaptor |
| 01/28/1999 | WO1999004003A1 Process of producing transgenic plants in which flowering is inhibited, and dna sequences used in said process |
| 01/28/1999 | WO1999004002A1 Human matrilin-3 |
| 01/28/1999 | WO1999004001A1 Tumor necrosis factor receptor ztnfr-5 |
| 01/28/1999 | WO1999004000A1 Adipocyte-specific protein homologs |
| 01/28/1999 | WO1999003999A1 Methods and compositions for inhibiting the proinflammatory response |
| 01/28/1999 | WO1999003998A1 Methods and compositions for tumor reduction |
| 01/28/1999 | WO1999003997A1 Humanized and green fluorescent protein genes and methods |
| 01/28/1999 | WO1999003996A1 Modified dorsal tissue affecting factor and compositions |
| 01/28/1999 | WO1999003995A1 T-cell receptor beta-like protein |
| 01/28/1999 | WO1999003994A1 Suppressors of cytokine signaling socs16; related reagents |
| 01/28/1999 | WO1999003993A2 Suppressors of cytokine signaling; related reagents |
| 01/28/1999 | WO1999003992A1 Trail receptor |
| 01/28/1999 | WO1999003991A1 Proteins mediating switch recombination |
| 01/28/1999 | WO1999003990A1 64 human secreted proteins |
| 01/28/1999 | WO1999003989A1 Human atp-binding cassette transport protein |
| 01/28/1999 | WO1999003988A1 Process for producing purine nucleosides via fermentation |
| 01/28/1999 | WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | WO1999003986A2 Method to produce polyketides and polyketides |
| 01/28/1999 | WO1999003985A1 Glutenin genes and their uses |
| 01/28/1999 | WO1999003984A2 Proteases from gram-positive organisms |
| 01/28/1999 | WO1999003983A1 Strong early seed-specific gene regulatory region |
| 01/28/1999 | WO1999003982A1 Interleukin-20 |
| 01/28/1999 | WO1999003981A1 Nucleic acid expression constructs incorporating a heterologous intron whose natural position is within the 5'untranslated region of its gene |
| 01/28/1999 | WO1999003978A1 Novel synthetic genes for plant gums |
| 01/28/1999 | WO1999003977A1 Improved promoters for enhancing plant productivity |
| 01/28/1999 | WO1999003976A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 01/28/1999 | WO1999003975A1 Improved vanillin production |
| 01/28/1999 | WO1999003974A1 Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003889A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | WO1999003887A1 Derivatives of growth hormone and related proteins |
| 01/28/1999 | WO1999003886A1 Tropoelastin derivatives |